![]() |
Volumn 115, Issue 4, 2010, Pages 711-716
|
Maternal and neonatal outcomes after antepartum treatment of influenza with antiviral medications
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMANTADINE;
ANTIVIRUS AGENT;
M2 ION CHANNEL INHIBITOR;
OSELTAMIVIR;
RIMANTADINE;
UNCLASSIFIED DRUG;
ADOLESCENT;
ADULT;
ANTIVIRAL THERAPY;
ARTICLE;
BRAIN HEMORRHAGE;
COHORT ANALYSIS;
CONTROLLED STUDY;
DRUG SAFETY;
FEMALE;
FETUS MALFORMATION;
FETUS OUTCOME;
FETUS WEIGHT;
HUMAN;
HYPERBILIRUBINEMIA;
INCIDENCE;
INFLUENZA;
INTUBATION;
LENGTH OF STAY;
LIVE BIRTH;
MAJOR CLINICAL STUDY;
NECROTIZING ENTEROCOLITIS;
NEWBORN;
NEWBORN DEATH;
NEWBORN INTENSIVE CARE;
NEWBORN MORTALITY;
PREECLAMPSIA;
PREGNANCY;
PREGNANCY DIABETES MELLITUS;
PREGNANCY OUTCOME;
PREMATURE FETUS MEMBRANE RUPTURE;
PREMATURITY;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
SEIZURE;
SIDE EFFECT;
STILLBIRTH;
AMANTADINE;
ANTIVIRAL AGENTS;
ENTEROCOLITIS, NECROTIZING;
FEMALE;
HUMANS;
INFANT, NEWBORN;
INFLUENZA, HUMAN;
OSELTAMIVIR;
PREGNANCY;
PREGNANCY COMPLICATIONS, INFECTIOUS;
PREGNANCY OUTCOME;
RIMANTADINE;
|
EID: 77949909243
PISSN: 00297844
EISSN: None
Source Type: Journal
DOI: 10.1097/AOG.0b013e3181d44752 Document Type: Article |
Times cited : (72)
|
References (10)
|